Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalPublished in a peer-reviewed journal

True Versus Sham Thread Embedding Acupuncture for Spasticity-Related Symptoms and Disabilities in Multiple Sclerosis: Study Protocol

This publication outlines a study protocol for a randomized, sham-controlled trial involving 38 participants with multiple sclerosis and moderate-to-severe spasticity. The study aims to evaluate the effects of True TEA compared to Sham TEA, focusing on disability changes as the primary endpoint, with assessments at 4 and 12 weeks post-intervention.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Moderate
Outcome
Not reported

Why it matters

This study protocol is essential for understanding how effective True TEA may be in managing spasticity in people with MS, which can significantly impact their quality of life. However, results from this trial are currently unavailable.

What this does not prove

This is a protocol publication, and actual findings from the trial are not yet available.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
38 · basis not reported
Randomised
Yes
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-10-15
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
PwMS with moderate-to-severe spasticity
Size of effect
Not reported
Secondary endpoints
Numeric Rating Scale for Spasticity (NRS-S); walking ability (MSWS-12); activities of daily living (Barthel Index); pain (McGill Pain Questionnaire); fatigue (MFIS); sleep quality (PSQI); urinary symptoms (ABSST); mood (HADS); quality of life (EQ-5D-5L); overall treatment satisfaction
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (14)
study phaseThis is a protocol of a randomized, sham-controlled, patient-, assessor- and analyst-blinded, superiority clinical trial.
study designThis is a protocol of a randomized, sham-controlled, patient-, assessor- and analyst-blinded, superiority clinical trial.
subjectsThirty-eight eligible PwMS with moderate-to-severe spasticity will be randomized 1:1 to either TTEA or STEA.
sample sizeThirty-eight eligible PwMS with moderate-to-severe spasticity will be randomized 1:1 to either TTEA or STEA.
randomizedThirty-eight eligible PwMS with moderate-to-severe spasticity will be randomized 1:1 to either TTEA or STEA.
controlledThis is a protocol of a randomized, sham-controlled, patient-, assessor- and analyst-blinded, superiority clinical trial.
primary endpointThe primary outcome is change in disability (EDSS).
follow upAssessments will be conducted at baseline, 4 weeks, and 12 weeks post-intervention.
findingsThis is a study that protocol aims to evaluate the efficacy and safety of True TEA (TTEA) compared with Sham TEA (STEA) in reducing spasticity and improving mobility and related symptoms among PwMS.
populationThirty-eight eligible PwMS with moderate-to-severe spasticity will be randomized 1:1 to either TTEA or STEA.
secondary endpointsSecondary outcomes are Numeric Rating Scale for Spasticity (NRS-S), walking ability (MSWS-12), activities of daily living (Barthel Index), pain (McGill Pain Questionnaire), fatigue (MFIS), sleep quality (PSQI), urinary symptoms (ABSST), mood (HADS), quality of life (EQ-5D-5L), overall treatment satisfaction, willingness to repeat and recommendation to others.
publication datePublication date: 2026-10-15
limitationsTitle: True Versus Sham Thread Embedding Acupuncture for Spasticity-Related Symptoms and Disabilities in Multiple Sclerosis: Study Protocol of a Randomized Controlled Trial.
peer reviewedPublication types: Journal Article

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.